心脏衰竭和中风:一个叙事审查
Takehiro Katano1, Hitoshi Mori2, Satoshi Suda1
1Department of Neurology, Nippon Medical School, Tokyo 113-8602, Japan.
Journal of clinical medicine
|September 13, 2025
概括
心力衰竭 (HF) 和中风相互关联,增加了全球健康负担. 了解它们的复杂关系对于改善患者的治疗结果和未来对心血管和脑血管疾病的研究至关重要.
科学领域:
- 心脏病学和神经病学
- 老年医学 老年医学
- 公共卫生 公共卫生
背景情况:
- 全球老龄化人口正在经历心力衰竭 (HF) 病例的增加,被称为HF流行病.
- 高血压明显与缺血性和出血性中风有关,加剧了脑血管疾病的全球负担.
- 心房动 (AF) 经常与HF共存,增加缺血性中风的风险.
研究的目的:
- 综合审查心力衰竭和中风之间的病理生理学和临床相互关系.
- 为未来的研究和对这些相互关联的疾病的临床管理提供最新的见解.
- 为了突出了解高频-中风联系的重要性,在不断增长的老年人口背景下.
主要方法:
- 文献综述综合了当前关于HF和中风的研究.
- 分析连接心脏和脑血管事件的病理生理机制.
- 检查临床数据和流行病学趋势.
主要成果:
- 心力衰竭和中风有共同的风险因素和病理生理路径.
- 这两种疾病的患病率在全球范围内都在增加,特别是在老年人群中.
- 有效的心力衰竭管理,包括心力衰竭的"四大"疗法,可以影响中风风险.
结论:
- 更深入地了解HF和中风之间的相互作用对于改善患者护理至关重要.
- 需要进一步的研究来阐明具体的机制,并制定有针对性的干预措施.
- 综合的临床管理策略对于解决HF和中风的双重负担至关重要.
相关概念视频
Heart Failure I: Introduction
710
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
710
Heart Failure II: Pathophysiology
734
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
734
Ischemic Heart Disease: Overview
3.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure Drugs: β-Blockers
772
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
772
Heart Failure IV: Classification and Diagnostic Evaluation
323
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
323


